Chris Shibutani
Stock Analyst at Goldman Sachs
Total Price Targets
21
Stocks Covered
11
Sectors
Healthcare
Most Recent
Oct 30, 2024
Stocks Covered by Chris Shibutani
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | $33.00 | $26.38 | +25.1% | 4 | Oct 30, 2024 |
| EXEL | Exelixis, Inc. | $18.00 | $43.81 | -58.9% | 2 | Oct 16, 2024 |
| JNJ | Johnson & Johnson | $159.00 | $227.97 | -30.3% | 3 | Oct 16, 2024 |
| SDGR | Schrödinger, Inc. | $27.00 | $12.37 | +118.4% | 2 | Sep 23, 2024 |
| RPRX | Royalty Pharma plc | $51.00 | $49.41 | +3.2% | 2 | Sep 4, 2024 |
| LLY | Eli Lilly and Company | $856.00 | $961.67 | -11.0% | 3 | Aug 9, 2024 |
| BMY | Bristol-Myers Squibb Company | $57.00 | $58.22 | -2.1% | 1 | Jul 29, 2024 |
| ERAS | Erasca, Inc. | $7.00 | $10.13 | -30.9% | 1 | Apr 1, 2024 |
| UTHR | United Therapeutics Corporation | $215.00 | $571.24 | -62.4% | 1 | Feb 12, 2024 |
| MRK | Merck & Co., Inc. | $93.00 | $111.89 | -16.9% | 1 | Dec 17, 2021 |
| NKTR | Nektar Therapeutics | $24.00 | $86.71 | -72.3% | 1 | May 18, 2021 |
Recent Activity
- Oct 30, 2024— Set$33.00price target onPFE(Pfizer Inc.)
- Oct 16, 2024— Set$159.00price target onJNJ(Johnson & Johnson)
- Oct 16, 2024— Set$18.00price target onEXEL(Exelixis, Inc.)
- Sep 23, 2024— Set$27.00price target onSDGR(Schrödinger, Inc.)
- Sep 4, 2024— Set$51.00price target onRPRX(Royalty Pharma plc)
- Aug 9, 2024— Set$856.00price target onLLY(Eli Lilly and Company)
- Jul 31, 2024— Set$34.00price target onPFE(Pfizer Inc.)
- Jul 29, 2024— Set$57.00price target onBMY(Bristol-Myers Squibb Company)
- Jun 7, 2024— Set$50.00price target onRPRX(Royalty Pharma plc)
- May 30, 2024— Set$785.00price target onLLY(Eli Lilly and Company)
- May 30, 2024— Set$160.00price target onJNJ(Johnson & Johnson)
- Apr 1, 2024— Set$7.00price target onERAS(Erasca, Inc.)
- Feb 12, 2024— Set$215.00price target onUTHR(United Therapeutics Corporation)
- Dec 19, 2022— Set$23.00price target onSDGR(Schrödinger, Inc.)
- Dec 13, 2022— Set$60.00price target onPFE(Pfizer Inc.)
- Feb 8, 2022— Set$50.00price target onPFE(Pfizer Inc.)
- Jan 26, 2022— Set$163.00price target onJNJ(Johnson & Johnson)
- Dec 17, 2021— Set$236.00price target onLLY(Eli Lilly and Company)
- Dec 17, 2021— Set$93.00price target onMRK(Merck & Co., Inc.)
- May 18, 2021— Set$24.00price target onNKTR(Nektar Therapeutics)
Frequently Asked Questions
Who is Chris Shibutani?
Chris Shibutani is a stock analyst at Goldman Sachs covering 11 stocks primarily in Healthcare. They have issued 21 price targets since May 18, 2021.
What stocks does Chris Shibutani cover?
Chris Shibutani currently covers 11 stocks, including PFE, JNJ, LLY, EXEL, SDGR.
What is Chris Shibutani's latest price target?
Chris Shibutani's most recent price target was $33.00 on PFE (Pfizer Inc.), set on Oct 30, 2024.
What is Chris Shibutani's highest price target?
Chris Shibutani's highest issued price target is $856.00 on LLY, set on Aug 9, 2024.
More Analysts at Goldman Sachs
Coverage based on publicly published price targets. Not investment advice.